Just to reiterate what was previous said and maybe
Post# of 72440
Posted On: 10/06/2015 8:32:36 AM
Just to reiterate what was previous said and maybe a dd a little-
Cellceutix (CTIX) isn't counting on share price to fund the trials.
They have cash on hand and there are a lot of grants and funding out there, that our management has been very good at getting in on.
They have hospitals that are funding Kevitrin trials right now, all Cellceutix is doing is supplying the drug.
They have proven to be smart in the past to not go under. Remember they decided not to take the route on the drug for hyper- something or other. It was stated that the B-Om trial would be a quicker cheaper way to confirm the anti-inflammatory values, that would open up many gates. That is being smart with money! Don't forget there is a material agreement in place for B, we aren't paying anything for whatever it is being tested for and that could give us less hurdles to get to the finish line in other indications of B. Anyone that tries to tell you different, question their agenda.
The science has been moving forward at an amazing pace for any bio, not just a small no name bio. Don't let the ignorance fall upon you ears that Cellceutix has not maintained a very good pace on it's drugs. The Kevetrin trial did take longer than"expected" but the results also increased the value of that time! Not to mention the fact that Dana Farber running the trial adds a lot credibility to the drug it self! Anyone that tries to tell you different, question their agenda.
Up-list oh lala to blame Leo when he couldn't do anything is a farce, but just to set the record straight he never the only time frame he ever gave was he planned to up-list this year(2015). He doesn't control NASDAQ or the FDA he doesn't have the deep pockets to manipulate any of them either. The attack on the company and it's drugs is the sole reason we are down at these levels. Not mismanagement.Anyone that tries to tell you different, question their agenda.
The lawsuit, that is still not official, is frivolous and based on only false information. There is nothing that supports this suit. They have one person with 300 shares and now another one with 3k shares that has been involved in suits with the same law firm previously!
Now IMO- This is an amazing investment opportunity. Not many times these come available to retail like this. I believe there are bigger folks in the background and many are going to be shocked soon enough! The boss already covered, no honor among thieves!
It is coming!!!
Know what you own!!!
Cellceutix (CTIX) isn't counting on share price to fund the trials.
They have cash on hand and there are a lot of grants and funding out there, that our management has been very good at getting in on.
They have hospitals that are funding Kevitrin trials right now, all Cellceutix is doing is supplying the drug.
They have proven to be smart in the past to not go under. Remember they decided not to take the route on the drug for hyper- something or other. It was stated that the B-Om trial would be a quicker cheaper way to confirm the anti-inflammatory values, that would open up many gates. That is being smart with money! Don't forget there is a material agreement in place for B, we aren't paying anything for whatever it is being tested for and that could give us less hurdles to get to the finish line in other indications of B. Anyone that tries to tell you different, question their agenda.
The science has been moving forward at an amazing pace for any bio, not just a small no name bio. Don't let the ignorance fall upon you ears that Cellceutix has not maintained a very good pace on it's drugs. The Kevetrin trial did take longer than"expected" but the results also increased the value of that time! Not to mention the fact that Dana Farber running the trial adds a lot credibility to the drug it self! Anyone that tries to tell you different, question their agenda.
Up-list oh lala to blame Leo when he couldn't do anything is a farce, but just to set the record straight he never the only time frame he ever gave was he planned to up-list this year(2015). He doesn't control NASDAQ or the FDA he doesn't have the deep pockets to manipulate any of them either. The attack on the company and it's drugs is the sole reason we are down at these levels. Not mismanagement.Anyone that tries to tell you different, question their agenda.
The lawsuit, that is still not official, is frivolous and based on only false information. There is nothing that supports this suit. They have one person with 300 shares and now another one with 3k shares that has been involved in suits with the same law firm previously!
Now IMO- This is an amazing investment opportunity. Not many times these come available to retail like this. I believe there are bigger folks in the background and many are going to be shocked soon enough! The boss already covered, no honor among thieves!
It is coming!!!
Know what you own!!!
(0)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Keep in mind that message boards require you to agree to thier manipulation or you are a lying basher! Also remember those that accuse are often riddle with quilt of performing the same which they accuse.
Scroll down for more posts ▼